Understanding how viral genes affect antibiotic resistance in mycobacteria

Investigating the role of prophage encoded gene products on mycobacterial gene expression and intrinsic antibiotic resistance

NIH-funded research University of Maine Orono · NIH-10579008

This study is looking at how certain viral genes in a type of bacteria called Mycobacterium abscessus affect its ability to resist antibiotics, which is important for people with cystic fibrosis, as it could help find better treatments for tough infections.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Maine Orono NIH-funded
Lab location1 site (Orono, United States)
Project IDNIH-10579008 on NIH RePORTER

What this research studies

This research investigates the role of prophages, which are viral genes integrated into the genomes of mycobacteria, in regulating antibiotic resistance and gene expression. The focus is on Mycobacterium abscessus, a significant pathogen in cystic fibrosis patients, where traditional treatments often fail. By examining how these prophages influence the bacteria's response to antibiotics and their survival mechanisms, the research aims to uncover new strategies to combat drug-resistant infections. Patients may benefit from insights that could lead to improved treatment options for resistant mycobacterial infections.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit include patients with cystic fibrosis who are infected with Mycobacterium abscessus or other drug-resistant mycobacteria.

Not a fit: Patients with infections caused by non-mycobacterial pathogens or those without antibiotic resistance issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating drug-resistant mycobacterial infections.

How similar studies have performed: While the specific role of prophages in mycobacterial antibiotic resistance is a relatively novel area of investigation, similar approaches have shown promise in understanding bacterial resistance mechanisms in other contexts.

Where this research is happening

Orono, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.